{"id":"W4249510237","doi":"10.1108/prt.2010.12939aab.021","title":"Troy's Mergal BIT20 receives Canadian regulatory approval","year":2010,"lang":"en","type":"article","venue":"Pigment & Resin Technology","topic":"Legal Cases and Commentary","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Drug approval; Business; Political science; Medicine; Pharmacology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007774251,0.001008033,0.001715336,0.002425263,0.0168746,0.009208365,0.006527547,0.1092392,0.0428895],"category_scores_gemma":[0.03387903,0.001077135,0.0030942,0.00140742,0.00682981,0.002855145,0.003272096,0.04359867,0.008717938],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01829267,"about_ca_system_score_gemma":0.04489443,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.3633768,"about_ca_topic_score_gemma":0.7011952,"domain_scores_codex":[0.988552,0.001068032,0.0004443895,0.001084305,0.005515293,0.003336051],"domain_scores_gemma":[0.9784373,0.01280102,0.0005212648,0.0006128602,0.005609997,0.002017604],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008099652,0.00002535429,0.000228433,0.00009437942,0.00002066385,0.0009783332,0.0002808413,0.00004763588,0.0003082805,0.04530854,0.9450085,0.00761798],"study_design_scores_gemma":[0.00008094437,0.0000375571,0.0006807193,0.0003197964,0.00006147174,0.0002972943,0.0004555551,0.0001345631,0.0003950258,0.003421958,0.9940732,0.00004207183],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.003504593,0.005155918,0.0005118769,0.6881147,0.02552686,0.000206543,0.000554622,0.0002597804,0.2761651],"genre_scores_gemma":[0.02399764,0.002620614,0.0009439188,0.5704042,0.007124281,0.0001446453,0.0001770504,0.0001362739,0.3944514],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.6366232,"threshold_uncertainty_score":0.7225235,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.004724920524725738,"score_gpt":0.2325399599617466,"score_spread":0.2278150394370208,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}